Show
Sort by
-
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
-
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
-
- Journal Article
- A1
- open access
Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity
-
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
-
- Journal Article
- A1
- open access
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
-
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial
-
- Journal Article
- A2
- open access
Cov-MS : a community-based template assay for mass-spectrometry-based protein detection in SARS-CoV-2 patients
-
Successful outcome of disseminated Fusarium musae fungemia with skin localization treated with liposomal amphotericin B and voriconazole in a patient with acute myeloid leukemia
-
Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients : a comparative multicenter study
-
- Journal Article
- A1
- open access
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition : an expert opinion